The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia
Open Access
- 23 April 2026
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 40 (7) , 1-10
Abstract
Activation of oncogenes by hijacking immunoglobulin gene loci ( IG ) enhancers via chromosomal translocation is a common pathogenetic mechanism in B-cell malignancies, affecting 5–10% of chronic lymphocytic leukemia (CLL). The oncogenic partners in many of these cases remain unidentified. Therefore, we conducted a comprehensive analysis of 144 CLL samples with IGH- translocation excluding IGH :: BCL2 , IGH :: CCND1 , IGH :: BCL3 and IGH :: MYC . By combining fluorescence in situ hybridization (FISH) with whole-genome, targeted sequencing, and RNA expression profiling, we identified 25 IG -translocation partners; 12 were previously unreported. Of 142 cases, 107 (75%) displayed an unmutated IGHV . Genetic profiling showed a heterogenous distribution of chromosomal aberrations and recurrently mutated genes across the groups. Of 41 informative cases, 32 (78%) exhibited breakpoints driven by aberrant class-switch recombination (CSR), with prominent involvement of IGHM (9/41) and IGHG3 (9/41). Three cases with unmutated IGHV carried a juxtaposition of the IGH locus 5’ to the intact NKX2.6 gene in chromosome 8p21.2 due to illegitimate VDJ recombination, associated with significant ectopic upregulation of NKX2.6 transcriptional expression (FDR < 0.001, logFC: 15). Similarly, METRNL , located at the telomere of chromosome 17q25, was identified as a translocation partner gene in four cases. Our findings expand the spectrum of the oncogenic translocation partners targeting IGH in CLL.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB1074 B10N)
- Deutsche Forschungsgemeinschaft (SFB1074 B10N)
- Deutsche Forschungsgemeinschaft (SFB1074 B10N)
- Deutsche Forschungsgemeinschaft (SFB1074 B10N)
- Deutsche Forschungsgemeinschaft (SFB1074 B10N)
This publication has 76 references indexed in Scilit:
- IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomesAmerican Journal of Hematology, 2018
- Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic eventCancer Genetics, 2014
- BMI1, The polycomb‐group gene, is recurrently targeted by genomic rearrangements in progressive B‐cell leukemia/lymphomaGenes, Chromosomes and Cancer, 2013
- FISH and FICTION to Detect Chromosomal Aberrations in Lymphomas2012
- Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease courseAnnals of Hematology, 2011
- Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin‐2 stimulation: A Belgian multicentric studyGenes, Chromosomes and Cancer, 2009
- Identification of a potential role forPOU2AF1 andBTG4 in the deletion of 11q23 in chronic lymphocytic leukemiaGenes, Chromosomes and Cancer, 2005
- Secondary Abnormalities of Chromosome 6q in B-Cell Chronic Lymphocytic Leukemia: A Sequential Study of Karyotypic Instability in 51 PatientsAmerican Journal of Hematology, 1998
- Detection of 14q32.33 translocation and t(11;14) in interphase nuclei of chronic B-cell leukemia/lymphomas byin situ hybridizationInternational Journal of Cancer, 1997
- The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoireImmunology Today, 1994